VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DNA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DNAGinkgo Bioworks Holdings, Inc.
$10.25$670M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDNAQuarterly Financials

Ginkgo Bioworks Holdings, Inc. (DNA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ginkgo Bioworks Holdings, Inc. (DNA) quarterly income statement — complete revenue, gross profit & net income history

DNA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue19.47M33.4M38.84M49.6M48.32M43.85M89.05M56.21M37.94M34.76M55.43M80.57M
Revenue Growth %-59.7%-23.84%-56.39%-11.75%27.34%26.16%60.65%-30.24%-52.98%-64.64%-16.52%-44.29%
Cost of Goods Sold15.9M-8.15M12.8M14.82M12.05M9.62M9.99M13.72M9.2M6.61M6.92M18.1M
COGS % of Revenue81.63%-24.4%32.96%29.88%24.93%21.94%11.22%24.41%24.25%19.02%12.49%22.46%
Gross Profit3.58M41.55M26.04M34.78M36.27M34.23M79.06M42.48M28.74M28.14M48.51M62.47M
Gross Margin %18.37%124.4%67.04%70.12%75.07%78.06%88.78%75.59%75.75%80.98%87.51%77.54%
Gross Profit Growth %-90.14%21.39%-67.07%-18.13%26.2%21.61%62.98%-31.99%-50.72%-58.65%16.2%-22.59%
Operating Expenses74.95M112.3M116.05M100.32M125.24M137.83M134.26M265.43M206.74M206.26M334.9M246.62M
OpEx % of Revenue384.88%336.26%298.82%202.25%259.2%314.35%150.78%472.25%544.87%593.47%604.19%306.11%
Selling, General & Admin37.83M46.01M44.95M43.28M49.04M57.3M52.29M66.28M70.29M89.22M82.03M102.34M
SG&A % of Revenue194.26%137.78%115.75%87.25%101.5%130.67%58.72%117.93%185.24%256.72%147.98%127.02%
Research & Development49.92M50.13M69.35M53.37M70.92M76.38M77.01M134.22M136.46M117.04M156.66M144.28M
R&D % of Revenue256.34%150.1%178.57%107.59%146.78%174.19%86.48%238.8%359.63%336.75%282.63%179.08%
Other Operating Expenses-1000K1000K1000K1000K1000K1000K1000K1000K001000K0
Operating Income-71.37M-70.75M-90.02M-65.54M-88.97M-103.61M-55.2M-222.94M-178M-178.12M-286.39M-184.15M
Operating Margin %-366.51%-211.86%-231.78%-132.13%-184.13%-236.29%-61.99%-396.66%-469.12%-512.49%-516.68%-228.57%
Operating Income Growth %19.78%31.71%-63.06%70.6%50.02%41.83%80.72%-21.07%17.49%24.05%56.27%71.57%
EBITDA-58.58M-24.23M-75.85M-49.75M-73.6M-87.95M-38.03M-205.62M-165.13M-164.23M-265.33M-166.5M
EBITDA Margin %-300.79%-72.54%-195.3%-100.29%-152.33%-200.59%-42.71%-365.82%-435.2%-472.55%-478.68%-206.66%
EBITDA Growth %20.42%72.45%-99.42%75.81%55.43%46.45%85.67%-23.49%16.09%24.9%58.99%73.89%
D&A (Non-Cash Add-back)12.8M46.52M14.17M15.79M15.37M15.65M17.17M17.33M12.87M13.88M21.06M17.65M
EBIT-71.37M-81.39M-80.75M-61.87M-83.69M-159.14M-52.26M-158.02M-178M-302.77M-190.18M-184.15M
Net Interest Income3.6M40.86M5.74M6.08M6.08M7.24M9.25M10.31M11.71M13.21M15.02M14.35M
Interest Income3.6M40.86M5.74M6.08M6.08M7.34M9.25M10.31M11.71M13.3M15.02M14.35M
Interest Expense0000094K00093K00
Other Income/Expense-4.76M-10.64M9.26M4.96M-1.9M-4.25M-1.57M5.95M12.12M-33.77M-16.52M10.9M
Pretax Income-76.14M-81.39M-80.75M-60.58M-90.87M-107.86M-56.78M-216.99M-165.88M-211.89M-302.91M-173.25M
Pretax Margin %-390.98%-243.72%-207.93%-122.13%-188.06%-245.99%-63.76%-386.06%-437.17%-609.67%-546.48%-215.03%
Income Tax-80K-643K1K-283K88K-325K-375K190K31K-198K-22K67K
Effective Tax Rate %0.11%0.79%-0%0.47%-0.1%0.3%0.66%-0.09%-0.02%0.09%0.01%-0.04%
Net Income-82.59M-80.75M-80.75M-60.3M-90.96M-107.53M-56.4M-217.18M-165.91M-211.69M-302.89M-173.31M
Net Margin %-424.09%-241.8%-207.93%-121.56%-188.25%-245.25%-63.34%-386.4%-437.25%-609.1%-546.44%-215.12%
Net Income Growth %9.2%24.91%-43.18%72.24%45.18%49.2%81.38%-25.31%19.06%-19.91%54.8%74.09%
Net Income (Continuing)-76.06M-80.75M-80.75M-60.3M-90.96M-107.53M-56.4M-217.18M-165.91M-211.69M-302.89M-173.31M
Discontinued Operations-1000K00000000000
Minority Interest000000000000
EPS (Diluted)-1.39-1.43-1.45-1.10-1.68-2.07-1.08-4.23-3.32-4.31-6.21-3.60
EPS Growth %17.26%30.92%-34.26%74%49.4%51.97%82.61%-17.5%22.61%-11.95%62.23%78.2%
EPS (Basic)-1.39-1.43-1.45-1.10-1.68-2.07-1.08-4.23-3.32-4.28-6.21-3.59
Diluted Shares Outstanding59.56M55.46M55.63M54.86M54.24M51.89M52.25M51.38M49.99M49.47M48.77M48.34M
Basic Shares Outstanding59.56M55.46M55.63M54.86M54.24M51.89M52.24M51.33M49.93M49.11M48.77M48.14M
Dividend Payout Ratio------------